Scientists visualize assembly line gears in ribosomes, cell's protein factoryOctober 16, 2009Even as research on the ribosome, one of the cell's most basic machines, is recognized with a Nobel Prize, scientists continue to achieve new insights on the way ribosomes work. Ribosomes are factories inside cells where messages coming from genes are decoded and new proteins pieced together on an assembly line. For the first time, scientists have a detailed picture of the ribosome trapped together with elongation factor G (EF-G), one of the enzymes that nudges the assembly line to move forward. The results are published in the Oct. 16 issue of Science magazine. A team led by Venki Ramakrishnan at the MRC Laboratory of Molecular Biology in Cambridge, England analyzed crystals of the ribosome bound to EF-G using X-rays, and used the X-ray data to determine the molecular structure. One member of the team, Christine Dunham, PhD, recently joined Emory University School of Medicine's Department of Biochemistry as an assistant professor. The scientists obtained crystals by growing heat-tolerant bacteria found at thermal vents at the bottom of the ocean. They purified the ribosomes from the bacteria and then added polymers carefully selected to coax the ribosomes into lining up and forming crystals. In addition, they included an antibiotic - fusidic acid - which traps EF-G on the ribosome. Previous efforts to crystallize ribosomes together with EF-G led to EF-G being displaced from the crystals. Dunham says the team was able to visualize the ribosome bound to EF-G only by shaving off part of the ribosome. Modifying the bacterial gene that encoded a part of the ribosome with a "very strange and elongated protein shape" allowed crystals that included EF-G to form. Dunham says details from the new structure show that EF-G interacts closely with parts of the ribosome, suggesting how it moves the assembly line forward without slipping out of frame. In addition, it paves the way for studying interactions between the ribosome and other proteins similar to EF-G that fit into the same spot. In her own research, Dunham is examining how viruses such as HIV, upon hijacking ribosomes, use special tricks that cause the assembly line to slip, as well as how other antibiotics and toxin proteins interact with parts of the ribosome. Emory University |
|||||||||||||||||||||
| Related Ribosome Current Events and Ribosome News Articles Study reveals why certain drug combinations backfire Combination drug therapy has become a staple for treating many infections. For instance, doctors treat extensively drug resistant forms of tuberculosis with one drug that breaks down the pathogen's protective barriers and opens the door for another to deliver the deathblow. 2-pronged protein attack could be source of SARS virulence Ever since the previously unknown SARS virus emerged from southern China in 2003, University of Texas Medical Branch at Galveston virologists have focused on finding the source of the pathogen's virulence - its ability to cause disease. National Science Foundation congratulates Nobel Laureates in medicine/physiology, chemistry and economics The National Science Foundation (NSF) congratulates the 2009 Nobel laureates, particularly those who have received NSF funding over the years: Jack W. Szostak, who shared the prize in physiology or medicine; Thomas A. Steitz, who shared the prize in chemistry; and Elinor Ostrom and Oliver E. Williamson who earned the Sveriges Riksbank Prize in economic sciences in memory of Alfred Nobel 2009. What are the characteristics of clarithromycin-resistant Helicobacter pylori? Clarithromycin is currently one of the antibiotics used for eradication of Helicobacter pylori. However, reports of H. pylori resistance to this antibiotic are increasing worldwide. Scripps research scientists observe human neurodegenerative disorder in fruit flies A team of scientists from The Scripps Research Institute, Katholeike Universiteit Leuven, and the University of Antwerp, Belgium, among other institutions, has created a genetically modified fruit fly that mimics key features of Charcot-Marie-Tooth disease, a common neurodegenerative disorder that strikes about one out of every 2,500 people in the United States. NIST researchers 'all aglow' over new test of toxin strength A new National Institute of Standards and Technology (NIST) assay using a "glow or no glow" technique may soon help the U.S. Department of Homeland Security (DHS) defend the nation against a spectrum of biological weapons that could be used in a terrorist attack. Genetic switch potential key to new class of antibiotics Researchers have determined the structure of a key genetic mechanism at work in bacteria, including some that are deadly to humans, in an important step toward the design of a new class of antibiotics. Researchers study signaling networks that set up genetic code In a new study, researchers at the University of Illinois have identified and visualized the signaling pathways in protein-RNA complexes that help set the genetic code in all organisms. Mutations within a conservative region of HCV affects the therapy At least 200 million individuals are currently infected with hepatitis C virus (HCV) worldwide. Approximately 30%-50% of patients respond to interferon/ribavirin combination therapy. Researchers identify genes for thiostrepton, a powerful drug whose use is now limited Researchers at the Georgia Institute of Technology have identified the genetic machinery responsible for synthesizing thiostrepton, a powerful antibiotic produced by certain bacteria. Though effective against the dangerous MRSA (methicillin-resistant Staphylococcus aureus) and vancomycin-resistant enterococci, thiostrepton currently has only limited applications in humans because it is not water soluble. More Ribosome Current Events and Ribosome News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||